Archives
New WHO Guidance: Corticosteroids for COVID-19
3 Sep, 2020 | 11:20h | UTCCorticosteroids for COVID-19 – World Health Organization
News Release: WHO updates clinical care guidance with corticosteroid recommendations – World Health Organization
Commentaries: The WHO Now Recommends Cheap Steroids As a Life-Saving Treatment for Severe Covid-19 – Gizmodo AND Inexpensive steroids reduce deaths of hospitalized Covid-19 patients, WHO analysis confirms – STAT
Commentary on Twitter
🆕 guideline on use of dexamethasone & other corticosteroids advises:
✅ for oral or intravenous usage in treatment of patients with severe & critical #COVID19
❌ against usage in treatment of non-severe casesMore: https://t.co/eWHzRrYKvO
— World Health Organization (WHO) (@WHO) September 2, 2020
[Preprint] Randomized trial: Tocilizumab does not improve clinical status or mortality in hospitalized patients with COVID-19 pneumonia
3 Sep, 2020 | 11:19h | UTCTocilizumab in Hospitalized Patients With COVID-19 Pneumonia – medRxiv
Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic
3 Sep, 2020 | 11:15h | UTCCommentaries: COVID-19 has likely tripled depression rate, study finds – Boston University School of Medicine AND Pandemic’s Emotional Hammer Hits Hard – NPR AND Depression Increases More Than Three-Fold In Wake Of Pandemic, BU Study Finds – CommonHealth
Covid-19: Study found those younger than 40 had an infection fatality ratio (IFR) of 0.01%; those 60 or older had an IFR of 1.71%
3 Sep, 2020 | 11:18h | UTC
Commentary on Twitter
Age, sex, race affect death risk from #COVID-19. @FSPH_IUPUI study found those younger than 40 had fatality rate of 0.01%; those 60 or older 1.71%—2.5 times greater than #flu https://t.co/oT4BCVbVxe. @jblackburn_phd @aaronecarroll pic.twitter.com/wE6Ti0EG6E
— Annals of Int Med (@AnnalsofIM) September 2, 2020
COVID-19 sparks 12-fold increase in remote delivery of mental health care across the US
3 Sep, 2020 | 11:13h | UTCOriginal Study: The COVID-19 Telepsychology Revolution: A National Study of Pandemic-Based Changes in U.S. Mental Health Care Delivery – American Psychologist
Virus in the blood can predict severe COVID-19
3 Sep, 2020 | 11:11h | UTCVirus in the blood can predict severe COVID-19 – Karolinska Institutet
Original Study: SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study – Clinical Infectious Diseases
COVID-19 can wreck your heart, even if you haven’t had any symptoms
3 Sep, 2020 | 11:06h | UTCCOVID-19 Can Wreck Your Heart, Even if You Haven’t Had Any Symptoms – Scientific American
IDSA Podcast – Managing patients post-COVID-19: From symptoms to lasting complications
3 Sep, 2020 | 11:08h | UTC
Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection
3 Sep, 2020 | 11:10h | UTCOriginal Study: Combined point of care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G Spike Variant – Cell Reports Medicine
Fauci says COVID vaccine trials could end early if results are overwhelming
3 Sep, 2020 | 11:02h | UTCFauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming – Kaiser Health News
Randomized trial: Similar outcomes with immediate angiography vs. delayed angiography after cardiac arrest
3 Sep, 2020 | 10:58h | UTCCoronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial – JAMA Cardiology (free for a limited period)
Commentary: Angiography for Cardiac Arrest Survivors: No Need to Rush – MedPage Today (free registration required)
Commentary on Twitter
Coronary angiography after cardiac arrest without ST elevation. COACT Trial. Immediate angiography was not found to be superior to a strategy of delayed angiography with respect to outcomes at 1 year @JAMACardio @randreariba_rut https://t.co/07FIQjwTOQ
— Carles Falces (@CarlesFalces) September 3, 2020
[Abstract Only] CAR T-cell therapy for patients with relapsed or refractory large B-cell lymphomas
3 Sep, 2020 | 10:56h | UTCLisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study – The Lancet (link to abstract – $ for full-text)
Getting ready for the Covid-19 pandemic: Experience of a Brazilian hospital
3 Sep, 2020 | 11:00h | UTCGetting Ready for the Covid-19 Pandemic: Experience of a Brazilian Hospital – NEJM Catalyst
Randomized trial: Effect of low tidal volume vs. conventional tidal volume on postoperative pulmonary complications in patients undergoing major surgery
3 Sep, 2020 | 10:57h | UTCEffect of Intraoperative Low Tidal Volume vs Conventional Tidal Volume on Postoperative Pulmonary Complications in Patients Undergoing Major Surgery: A Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
Normal lungs and the humans containing them don’t seem to mind how they’re ventilated (within reason). https://t.co/EdGVjm7esU
— Greg Bryson, MD, FRCPC (@glbryson) September 2, 2020
23 bus passengers contracted coronavirus from 1 infected person. No one was wearing a mask.
2 Sep, 2020 | 10:09h | UTCOriginal Study: Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China – JAMA Internal Medicine
Commentary on Twitter
Outbreak on a bus in China is offering new evidence about SARSCoV2's airborne spread. A person on a poorly ventilated vehicle infected nearly 2 doz people even tho many weren't sitting nearby. Conclusion: mere breathing can send micro-droplets into the air https://t.co/plxzOrZLAT
— delthia ricks 🔬 (@DelthiaRicks) September 1, 2020
New #OpenWho Course: Occupational health and safety for health workers in the context of COVID-19
2 Sep, 2020 | 10:11h | UTC
Study: Face shields, masks with valves ineffective against COVID-19 spread
2 Sep, 2020 | 09:55h | UTCFace Shields, Masks with Valves Ineffective Against COVID-19 Spread – American Institute of Physics
Original Study: Visualizing droplet dispersal for face shields and masks with exhalation valves – Physics of Fluids
How many people has the coronavirus killed?
2 Sep, 2020 | 09:59h | UTCHow many people has the coronavirus killed? – Nature
Probable evidence of fecal aerosol transmission of SARS-CoV-2 in a high-rise building
2 Sep, 2020 | 10:07h | UTC
Commentary on Twitter
NEW❗ #Fecal aerosol transmission may have caused the community outbreak of #COVID19 in this high-rise building researchers investigated https://t.co/5TAJqSq0I0. pic.twitter.com/IbBOwzI1az
— Annals of Int Med (@AnnalsofIM) September 1, 2020
Opinion: Managing uncertainty in the Covid-19 era
2 Sep, 2020 | 09:49h | UTCManaging uncertainty in the covid-19 era – The BMJ
Commentary on Twitter
https://mobile.twitter.com/fibke/status/1300795813543673857
Humoral immune response to SARS-CoV-2 in Iceland
2 Sep, 2020 | 09:57h | UTCHumoral Immune Response to SARS-CoV-2 in Iceland – New England Journal of Medicine
Editorial: The Power of Antibody-Based Surveillance
Commentary on Twitter
I would never have guessed that IFR would become one of the most controversial topics of 2020
The IFR in today's @NEJM publication of the Iceland experience was 0.3% https://t.co/bkub1TcazK
The IFR in the preprint meta-analysis by satan was 0.27%
🤷♂️ pic.twitter.com/arz3cCKRvA— Vinay Prasad MD MPH (@VPrasadMDMPH) September 1, 2020
Meta-analysis: Clinical manifestations, risk factors, and maternal and perinatal outcomes of Covid-19 in pregnancy
2 Sep, 2020 | 09:52h | UTC
U.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine
2 Sep, 2020 | 09:46h | UTCU.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine – STAT
ADA Guideline synopsis: Pharmacologic approaches to glycemic treatment of Type 2 Diabetes
2 Sep, 2020 | 09:41h | UTC
#ESCCongress – [Not Published Yet] First randomized trial backs safety of ACE Inhibitors and ARBs in COVID-19 patients
2 Sep, 2020 | 09:48h | UTCNews Release: First randomised trial backs safety of common heart drugs in COVID-19 patients – European Society of Cardiology
Commentary on Twitter
Dr. Renato Lopes presents the BRACE CORONA trial: in patients hospitalized with COVID-19, suspending ACEI/ARB therapy for 30 days did not impact the number of days alive and out of hospital.
Full slide deck: https://t.co/avSK41bGSj#ESCCongress pic.twitter.com/2p0FH9U2RG
— C. Michael Gibson MD (@CMichaelGibson) September 1, 2020